ATE380249T1 - Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen - Google Patents
Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussenInfo
- Publication number
- ATE380249T1 ATE380249T1 AT99962013T AT99962013T ATE380249T1 AT E380249 T1 ATE380249 T1 AT E380249T1 AT 99962013 T AT99962013 T AT 99962013T AT 99962013 T AT99962013 T AT 99962013T AT E380249 T1 ATE380249 T1 AT E380249T1
- Authority
- AT
- Austria
- Prior art keywords
- mrna stability
- active substances
- transfected cells
- stable transfected
- affect mrna
- Prior art date
Links
- 108020004999 messenger RNA Proteins 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000014509 gene expression Effects 0.000 abstract 2
- 108700008625 Reporter Genes Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003571 reporter gene assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828709.7A GB9828709D0 (en) | 1998-12-24 | 1998-12-24 | Assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380249T1 true ATE380249T1 (de) | 2007-12-15 |
Family
ID=10845082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99962013T ATE380249T1 (de) | 1998-12-24 | 1999-12-23 | Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150176088A1 (de) |
| EP (1) | EP1141358B1 (de) |
| JP (1) | JP2002541767A (de) |
| AT (1) | ATE380249T1 (de) |
| AU (1) | AU776604C (de) |
| CA (1) | CA2356621C (de) |
| DE (1) | DE69937689T2 (de) |
| DK (1) | DK1141358T3 (de) |
| ES (1) | ES2299273T3 (de) |
| GB (1) | GB9828709D0 (de) |
| PT (1) | PT1141358E (de) |
| WO (1) | WO2000039314A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7598079B2 (en) | 1998-12-24 | 2009-10-06 | Novation Pharmaceuticals, Inc. | Assay for identifying compounds which affect stability of mRNA |
| JP2002533389A (ja) | 1998-12-24 | 2002-10-08 | ノーベーション ファーマシューティカルズ インコーポレーテッド | ｍＲＮＡ安定性に影響する化合物およびそのための使用 |
| CN100471956C (zh) * | 2001-03-09 | 2009-03-25 | 基因流股份有限公司 | 新型表达载体 |
| US7915306B2 (en) | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| US7799827B2 (en) | 2002-03-08 | 2010-09-21 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| US7399583B2 (en) | 2002-04-17 | 2008-07-15 | Novartis Ag | Method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein |
| JP4528623B2 (ja) * | 2002-09-16 | 2010-08-18 | プロメガ コーポレイション | 迅速分解性レポーター融合タンパク質 |
| EP2500437B1 (de) | 2003-01-21 | 2016-11-30 | PTC Therapeutics, Inc. | Verfahren zur Identifizierung von Verbindungen zur Modulation der Expression von Genen mit Abhängigkeit einer untranslatierten Region sowie Verfahren zu deren Verwendung |
| US8426194B2 (en) | 2003-01-21 | 2013-04-23 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating VEGF expression |
| US9068234B2 (en) | 2003-01-21 | 2015-06-30 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating gene expression |
| EA201200555A1 (ru) | 2004-03-15 | 2013-01-30 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Производные карболина, полезные в ингибировании ангиогенеза |
| US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
| US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
| US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
| US8283115B1 (en) | 2007-06-20 | 2012-10-09 | Ptc Therapeutics, Inc. | Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation |
| US8283116B1 (en) | 2007-06-22 | 2012-10-09 | Ptc Therapeutics, Inc. | Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation |
| AU2008279027B8 (en) | 2007-07-25 | 2014-03-06 | Eisai R & D Management Co., Ltd. | Multikinase inhibitors for use in the treatment of cancer |
| CA2996064C (en) | 2015-08-18 | 2024-02-13 | Novation Pharmaceuticals Inc. | Benzopyran derivatives and uses thereof |
| KR20220139426A (ko) * | 2016-03-31 | 2022-10-14 | 버클리 라잇츠, 인크. | 핵산 안정화 시약, 키트들, 및 그 이용 방법들 |
| CN116426610B (zh) * | 2023-06-08 | 2024-01-05 | 启辰生生物科技(珠海)有限公司 | 一种LC-MS法准确定量mRNA加帽效率的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174666B1 (en) * | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
| WO1995033831A1 (en) * | 1994-06-07 | 1995-12-14 | Creative Biomolecules, Inc. | Methods and compositions for modulating morphogenic protein expression |
| US5731343A (en) * | 1995-02-24 | 1998-03-24 | The Scripps Research Institute | Method of use of radicicol for treatment of immunopathological disorders |
| KR20010082554A (ko) * | 1998-05-26 | 2001-08-30 | 추후보정 | Ｒｎａ 분자의 안정성 및 교체성을 재현 및 조절하기 위한시스템 |
-
1998
- 1998-12-24 GB GBGB9828709.7A patent/GB9828709D0/en not_active Ceased
-
1999
- 1999-12-23 DK DK99962013T patent/DK1141358T3/da active
- 1999-12-23 CA CA2356621A patent/CA2356621C/en not_active Expired - Lifetime
- 1999-12-23 ES ES99962013T patent/ES2299273T3/es not_active Expired - Lifetime
- 1999-12-23 PT PT99962013T patent/PT1141358E/pt unknown
- 1999-12-23 EP EP99962013A patent/EP1141358B1/de not_active Expired - Lifetime
- 1999-12-23 DE DE69937689T patent/DE69937689T2/de not_active Expired - Lifetime
- 1999-12-23 WO PCT/CA1999/001235 patent/WO2000039314A1/en not_active Ceased
- 1999-12-23 JP JP2000591204A patent/JP2002541767A/ja active Pending
- 1999-12-23 AU AU18522/00A patent/AU776604C/en not_active Ceased
- 1999-12-23 AT AT99962013T patent/ATE380249T1/de not_active IP Right Cessation
-
2014
- 2014-12-10 US US14/566,621 patent/US20150176088A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150176088A1 (en) | 2015-06-25 |
| AU1852200A (en) | 2000-07-31 |
| CA2356621A1 (en) | 2000-07-06 |
| AU776604C (en) | 2005-05-12 |
| EP1141358B1 (de) | 2007-12-05 |
| CA2356621C (en) | 2013-03-26 |
| WO2000039314A1 (en) | 2000-07-06 |
| PT1141358E (pt) | 2008-03-17 |
| JP2002541767A (ja) | 2002-12-10 |
| ES2299273T3 (es) | 2008-05-16 |
| DK1141358T3 (da) | 2008-03-31 |
| AU776604B2 (en) | 2004-09-16 |
| GB9828709D0 (en) | 1999-02-17 |
| DE69937689T2 (de) | 2008-08-28 |
| EP1141358A1 (de) | 2001-10-10 |
| DE69937689D1 (de) | 2008-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69937689D1 (de) | Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen | |
| DE69822206D1 (de) | Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen | |
| ATE404695T1 (de) | Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen | |
| NO20025402L (no) | Modifiserte ES-celler og ES-cellespesifikke gener | |
| DE69606352D1 (de) | Additvthaltige Kathoden für elektrochemische Zellen | |
| WO2003093469A3 (en) | Methods for delivering nucleic acid molecules into cells and assessment thereof | |
| TR199800046A2 (xx) | Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu. | |
| WO2004065581A3 (en) | Transposon-insulator element delivery systems | |
| WO2002029113A3 (en) | Methods for monitoring multiple gene expression | |
| DE69906574D1 (de) | Vorrichtung zum züchten von organischen zellen und erforschung ihrer elektrophysiologischen aktivität und dabei verwendete membran | |
| EP1131333A4 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| DE69930837D1 (de) | Verwendung von katalysatoren in ventilgeregelten stand-by bleisäure zellen | |
| DE59813976D1 (de) | Optimierung von Zellen für die endogene Genaktivierung | |
| Lau et al. | Tissue-specific and imprinted epigenetic modifications of the human NDN gene | |
| Berton et al. | Activation of fibroblasts in collagen lattices by mast cell extract: a model of fibrosis | |
| WO2003095608A3 (en) | Dna microarrays comprising active chromatin elements and comprehensive profiling therewith | |
| DE69942063D1 (de) | Antagonisten von 'hedgehog' und 'patched' zur inhibierung des wachstums und der differenzierung von zellen und geweben, als auch deren verwendungen | |
| ATE267396T1 (de) | Identifizierung von zellen während kinetischer versuchsreihen | |
| ATE304595T1 (de) | Lichtproduzierender biosensor | |
| WO2002000871A3 (de) | Verfahren zur einbringung von nukleinsäuren und anderen biologisch aktiven molekülen in der kern höherer eukaryontischer zellen mit hilfe elektrischen stroms | |
| WO2004022782A3 (en) | Compositions and methods for tissue specific or inducible inhibition of gene expression | |
| DE69937959D1 (de) | Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration | |
| DE60027735D1 (de) | Genetische screeningverfahren | |
| DE60130465D1 (de) | Mutierte muskelspezifische enhancer | |
| WO2003006947A3 (en) | Cell-screening assay and composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1141358 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |